Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Four Firms Vie For Medicare 2014 New-Tech Add-On Payments

This article was originally published in The Gray Sheet

Executive Summary

CMS held its annual new-technology Town Hall Feb. 5, hearing from applicants for a drug-eluting peripheral artery stent, a neurostimulator system for epilepsy seizures, a transcatheter mitral valve repair system and a retinal prosthesis system.

Advertisement

Related Content

Medicare Bonus Payments Awarded To Cook’s Stent, Second Sight’s Eye Implant
Medicare Bonus Payments Awarded To Cook’s Stent, Second Sight’s Eye Implant
FDA Advisors Vote That Benefits Of Abbott’s MitraClip Outweigh Risks
FDA Advisors Vote That Benefits Of Abbott’s MitraClip Outweigh Risks
New Products In Brief
FDA Panel: Argus II Artificial Retina’s Benefits Outweigh Risks
Cook’s Zenith Fenestrated AAA Graft Nets Positive Payment Rulings In Medicare Reg
Cook Medical Makes Its Case For Medicare New-Tech Add-On Payments
Abbott Expects To Resume Shipments Of Recalled MitraClip In Several Months
ACC Meeting In Brief

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT032719

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel